Authors: Monastirli, A Georgiou, S Bolsen, K Pasmatzi, E Papapanagiotou, A Goerz, G Kalofoutis, A Merk, HF Tsambaos, D

Citation: A. Monastirli et al., Treatment of porphyria cutanea tarda with oral thalidomide, SKIN PH APP, 12(6), 1999, pp. 305-311

Authors: Kalofoutis, A Monastirli, A Papapanagiotou, A Georgiou, S Pasmatzi, E Sakkis, T Bolsen, K Goerz, G Merk, HF Tsambaos, D

Citation: A. Kalofoutis et al., Alterations of rat liver phospholipid composition induced by oral thalidomide, SKIN PH APP, 12(6), 1999, pp. 312-316

Authors: Kalofoutis, A Bakogianni, M Papapanagiotoy, A Baschali, A

Citation: A. Kalofoutis et al., Effects of prostaglandin E-1 on high density lipoprotein-phospholipid composition, PROS LEUK E, 61(5), 1999, pp. 303-306

Authors: Bakogianni, M Papapanagiotou, A Zachari, A Kalofoutis, A

Citation: M. Bakogianni et al., Changes in high-density lipoprotein serum subfractions in patients with non-insulin dependent diabetes mellitus drawn from a Greek population, MED SCI RES, 27(8), 1999, pp. 521-522

Authors: Kalofoutis, A Papapanagiotou, A Hatjioannou, A Maravelias, K

Citation: A. Kalofoutis et al., Changes in human serum high density lipoprotein induced by hashish constituents, MED SCI RES, 27(2), 1999, pp. 117-118

Authors: Kalofoutis, A Papapanagiotou, A Tzivras, M

Citation: A. Kalofoutis et al., Clinical significance of plasma HDL subfractions (HDL2, HDL3) in patients with peripheral arterial disease (PAD) in the Greek population, CLIN BIOCH, 32(2), 1999, pp. 149-152